Professor, Medicine, University of Miami School of Medicine
Internal Medicine
Dr. Michael A. Kolber, MD
|
|
Give Review
Doctor Michael A. Kolber, MD is an expert in the field of Internal Medicine. He studied medicine at University of Miami Miller School of Medicine. University of Miami Miller School of Medicine is ranked 45 in research and 0 in primary care medicine Michael Kolber is a published MD. He has 59 papers published. The most current publication "In vitro enhancement of T-cell receptor-targeted lysis after IL-2 treatment of PBL from HIV-seropositive individuals." He accepts all Medicare patients.
Publications
- Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
- High Interest in Pre-exposure Prophylaxis Among Men Who Have Sex with Men at Risk for HIV-Infection: Baseline Data from the US PrEP Demonstration Project.
- Preventing HIV infection: Pre-exposure and postexposure prophylaxis.
- HIV medical providers' perceptions of the use of antiretroviral therapy as nonoccupational postexposure prophylaxis in 2 major metropolitan areas.
- Cutting Edge: Novel Vaccination Modality Provides Significant Protection against Mucosal Infection by Highly Pathogenic Simian Immunodeficiency Virus.
- Demographic and psychosocial factors associated with appointment attendance among HIV-positive outpatients.
- HIV-1 diversity after a class switch failure.
- An academic center's delivery of care after the Haitian earthquake.
- Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation.
- Differences in HIV-related hospitalization trends between Haitian-born blacks and US-born blacks.
- Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus...
- Differences in presentation and outcome of invasive pneumococcal disease among patients with and without HIV infection in the pre-HAART era.
- Memory responses in human immunodeficiency virus type 1-infected individuals with long-term viral load suppression are independent of CD4 cell nadir.
- Impact of immune plasticity on development of cellular memory responses to human immunodeficiency virus type 1.
- Antigen-presenting cell modulation induces a memory response to p24 in peripheral blood leukocytes from human immunodeficiency virus-infected individuals.
- Effect of class-specific therapy interruption on persistence of HIV type 1 antiretroviral resistance.
- Differences in the frequency of resistance to antiretroviral drug classes among human immunodeficiency virus type 1 clinical isolates.
- An observer-blinded study of 1% permethrin creme rinse with and without adjunctive combing in patients with head lice.
- Development of drug resistance mutations in patients on highly active antiretroviral therapy: does competitive advantage drive evolution.
- Gp96 SIV Ig immunization induces potent polyepitope specific, multifunctional memory responses in rectal and vaginal mucosa.
- IL-21 augments natural killer effector functions in chronically HIV-infected individuals.
- CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
- A K103N resistance mutation is not an absolute contraindication to adding efavirenz to a salvage regimen: a case report.
- Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patients.
- Development of anti-retroviral resistance of HIV-1 infected individuals on therapy: is it inevitable?
- Efficacy of indinavir-ritonavir-based regimens in HIV-1-infected patients with prior protease inhibitor failures.
- Genotypic analysis of plasma HIV-1 RNA after influenza vaccination of patients with previously undetectable viral loads.
- Enhancement of antigen driven lymphocyte proliferation secondary to GP41-induced B7 expression on adherent monocytes.
- In vitro enhancement of T-cell receptor-targeted lysis after IL-2 treatment of PBL from HIV-seropositive individuals.
- Evidence of increased class I MHC expression on human peripheral blood lymphocytes during acute ethanol intoxication.
- Measurement of cytotoxicity by target cell release and retention of the fluorescent dye bis-carboxyethyl-carboxyfluorescein (BCECF).
- Quantitation of secretion by rat basophilic leukemia cells by measurements of quinacrine uptake.
- Fluorescence study of the divalent cation-transport mechanism of ionophore A23187 in phospholipid membranes.
- Mono- and divalent competitive adsorption to charged membrane in a closed system: a comparative study.
- Competitive membrane adsorption of Na+, K+, and Ca2+ in smooth muscle cells.
- Evidence for a role of phosphatidyl ethanolamine as a modulator of membrane-membrane contact.
- A new method for measuring the kinetics of transmembrane calcium-45 efflux in the smooth muscle of the guinea pig tanea coli.
- Short and long-range forces involved in cation-induced aggregation of chromaffin granule membranes.
- Vincristine potentiates cytochalasin B-induced DNA fragmentation in vitro.
- Human cytotoxic T lymphocytes and activated peripheral blood lymphocytes enhance cytochalasin B-induced DNA fragmentation of indicator bystander cells.
- Cytotoxic T lymphocytes can be generated against acetaldehyde-modified syngeneic cells.
- Enhancement of redirected target cell lysis by cytotoxic T lymphocytes in the presence of cytochalasin B.
- The generation of cytotoxic T lymphocytes against acetaldehyde-modified syngeneic cells.
- Cytochalasin B induces cellular DNA fragmentation.
- Hydrolysis of inositol phospholipids induced by stimulation of the T cell antigen receptor complex in antigen-specific, murine helper T cell clones. Requirement for ex...
- Ethanol: an enhancer of transplantation antigen expression.
- Target cell lysis by cytotoxic T lymphocytes redirected by antibody-coated polystyrene beads.
- Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk fo...
- The safety and efficacy of indinavir and ritonavir (400/400 mg BID) in HIV-1-infected individuals from an inner-city minority population: a pilot study.
- Cell-secreted Gp96-Ig-peptide complexes induce lamina propria and intraepithelial CD8+ cytotoxic T lymphocytes in the intestinal mucosa.
- Race and ethnicity impact on the maximum proliferative response in peripheral blood lymphocytes from HIV-seropositive individuals.
- Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 2).
- Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 1).
- Would switching the protease inhibitors (PI) to tenoforvir be an option in controlling hypertriglyceridaemia secondary to PIs? A case report.
- Norepinephrine and GTP-gamma-S increase myofilament Ca2+ sensitivity in alpha-toxin permeabilized arterial smooth muscle.
- Wernicke''s encephalopathy in AIDS: a preventable cause of fatal neurological deficit.
- Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal virus.
- Shoulder pain in wheelchair users with tetraplegia and paraplegia.
Schools
University of Miami School of Medicine
George Washington University Med Center
National Institute Health
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
National Institutes of Health Clinical Center -
George Washington University -
University of Miami Miller School of Medicine
Hospital
-
University of Miami Hospital
Drug Facts
| NPI NUMBER | 1578528279 | |
| NPPES Provider LastName | KOLBER | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 331361005 | |
| NPPES Provider State | FL | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 740.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 1.49 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1578528279 |
| Last Name Of The Provider | KOLBER |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Antonia P. Eyssallenne, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce R. Troen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharon Goldberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose Moya, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danielle L. Selema, DO |